MedDataX Logo

The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma

NCT ID: NCT04205201

Last Updated: 2019-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-25

Study Completion Date

2019-10-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Outpatient department of cmch, ceitc,cimch POAG patients enrolled for the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Caregivers
Generated by pharmaceutical companies.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Latanoprost

Group Type EXPERIMENTAL

Drugs, Investigational

Intervention Type DRUG

To see the safety and efficacy of topical latanoprost compared with topical brimonidine in the treatment of the primary open angle

Group B

Brimonidine

Group Type OTHER

Drugs, Investigational

Intervention Type DRUG

To see the safety and efficacy of topical latanoprost compared with topical brimonidine in the treatment of the primary open angle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Drugs, Investigational

To see the safety and efficacy of topical latanoprost compared with topical brimonidine in the treatment of the primary open angle

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Brimonidine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* IOP 22\_34mmof Hg,newly diagnosed case, bilateral POAG patients Patients.

Exclusion Criteria

* pregnant and lactating women, infection, any eye surgery.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chittagong Medical College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Abul Khayer

Student

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Facuity of basic science and para clinical science

Dhaka, Chittagong, Bangladesh

Site Status

Facuity of basic scienceand para clinican science

Chittagong, Chokhbazar, Bangladesh

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bangladesh

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CMC/PG/2018/1828

Identifier Type: -

Identifier Source: org_study_id